Orient Pharma Co., Ltd. (TPEX:4166)
Taiwan · Delayed Price · Currency is TWD 24.40
+1.10 (4.72%)
May 29, 2026, 1:30 PM CST
Orient Pharma Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 196.58 | 208.44 | 107.37 | 22.29 | -28.76 | -102.65 |
Depreciation & Amortization | 134 | 133.99 | 134.35 | 134.35 | 66.24 | 60.23 |
Other Amortization | 1.62 | 1.62 | 1.37 | 1.22 | 2.86 | 4.95 |
Loss (Gain) From Sale of Assets | 0.09 | 0.22 | - | 0.04 | 0.13 | - |
Asset Writedown & Restructuring Costs | 13.22 | 8.65 | - | - | - | 10 |
Stock-Based Compensation | 0.48 | 0.48 | - | - | - | 0.14 |
Provision & Write-off of Bad Debts | 8.81 | 6 | 16 | 3.44 | - | - |
Other Operating Activities | 38.89 | 42.56 | 59.46 | 4.94 | 11.15 | -4.12 |
Change in Accounts Receivable | -1.22 | 27.74 | -111.7 | -95.37 | -6.31 | 15.12 |
Change in Inventory | -52.41 | -47.11 | -56.57 | -43.67 | -62.23 | -25.38 |
Change in Accounts Payable | 3.84 | 26.44 | -19.78 | -6.37 | 42.64 | -9.01 |
Change in Unearned Revenue | -60.04 | -60.04 | 42.5 | -42.86 | -13.2 | 33.34 |
Change in Other Net Operating Assets | 23.25 | 10.87 | 22.71 | -80.99 | -1.14 | -36.17 |
Operating Cash Flow | 307.12 | 359.86 | 195.71 | -102.99 | 11.38 | -53.57 |
Operating Cash Flow Growth | -0.70% | 83.87% | - | - | - | - |
Capital Expenditures | -61.11 | -35.82 | -27.33 | -54.11 | -28.4 | -66.54 |
Sale of Property, Plant & Equipment | - | - | - | - | 0.26 | - |
Sale (Purchase) of Intangibles | -14.13 | -13.68 | -0.09 | -19.4 | -0.52 | -3.46 |
Investment in Securities | - | -15 | 5 | -9 | - | 120 |
Other Investing Activities | -8.85 | -8.57 | -0.06 | -5.5 | -0.42 | 5.81 |
Investing Cash Flow | -84.09 | -73.07 | -22.48 | -88.02 | -29.09 | 55.81 |
Short-Term Debt Issued | - | - | - | 246 | - | 129.5 |
Long-Term Debt Issued | - | - | - | - | 133 | - |
Total Debt Issued | 60 | - | - | 246 | 133 | 129.5 |
Short-Term Debt Repaid | - | -250 | -64.5 | - | -93 | - |
Long-Term Debt Repaid | - | -100.54 | -108.86 | -48.1 | -76.79 | -48.79 |
Total Debt Repaid | -393.49 | -350.54 | -173.36 | -48.1 | -169.79 | -48.79 |
Net Debt Issued (Repaid) | -333.49 | -350.54 | -173.36 | 197.9 | -36.79 | 80.71 |
Issuance of Common Stock | 568.57 | 568.57 | - | - | - | - |
Other Financing Activities | - | - | - | - | - | -1.6 |
Financing Cash Flow | 235.08 | 218.03 | -173.36 | 197.9 | -36.79 | 79.11 |
Foreign Exchange Rate Adjustments | -1.97 | -1.72 | 1.3 | - | 0 | -0 |
Net Cash Flow | 456.14 | 503.1 | 1.18 | 6.89 | -54.49 | 81.34 |
Free Cash Flow | 246.01 | 324.04 | 168.38 | -157.1 | -17.01 | -120.1 |
Free Cash Flow Growth | -13.21% | 92.44% | - | - | - | - |
Free Cash Flow Margin | 17.39% | 23.14% | 13.77% | -17.65% | -3.32% | -25.92% |
Free Cash Flow Per Share | 1.10 | 1.41 | 0.76 | -0.70 | -0.09 | -0.64 |
Cash Interest Paid | 7.98 | 7.98 | 14.42 | 13.42 | 7.44 | 5.62 |
Cash Income Tax Paid | 0.93 | 0.93 | 2.93 | 0.04 | 1.37 | 3.9 |
Levered Free Cash Flow | 143.34 | 224.36 | 96.9 | -188.04 | -11.17 | -101.34 |
Unlevered Free Cash Flow | 147.09 | 229.3 | 105.63 | -179.35 | -6.56 | -97.77 |
Change in Working Capital | -86.58 | -42.1 | -122.84 | -269.26 | -40.24 | -22.11 |